Peter Hirth
Impact in
- Molecular Biology top 1%
- Melanoma and MAPK Pathways
- Protein Kinase Regulation and GTPase Signaling
- Developmental Biology and Gene Regulation
- Angiogenesis and VEGF in Cancer
-
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Erythropoietin and Anemia Treatment 4
-
- Melanoma and MAPK Pathways 6
- RNA and protein synthesis mechanisms 1
- Co-authors
- Norbert Felix Voelkel (3 shared papers)Rubin M. Tuder (3 shared papers)Laimute Taraseviciene‐Stewart (3 shared papers)Gerald McMahon (5 shared papers)Yasunori Kasahara (2 shared papers)Johannes L. Waltenberger (2 shared papers)Cho Tang (3 shared papers)Li Sun (2 shared papers)
- Journals
- Nature (3 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Investigation (1 paper)Canadian Journal of Physiology and Pharmacology (1 paper)Journal of Molecular Medicine (1 paper)
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Peter Hirth
23 papers receiving 7.4k citations
Peter Hirth's Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 3.4k
- Pulmonary and Respiratory Medicine 1.6k
- Computational Theory and Mathematics 692
- Oncology 599
- Organic Chemistry 692
Countries citing papers authored by Peter Hirth
This map shows the geographic impact of Peter Hirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hirth more than expected).
Fields of papers citing papers by Peter Hirth
This network shows the impact of papers produced by Peter Hirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hirth. The network helps show where Peter Hirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma Hit paper breakdown → | 2010 | 1516 |
| 2 | Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity Hit paper breakdown → | 2008 | 1134 |
| 3 | Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors Hit paper breakdown → | 1997 | 998 |
| 4 | Inhibition of VEGF receptors causes lung cell apoptosis and emphysema Hit paper breakdown → | 2000 | 939 |
| 5 | Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension Hit paper breakdown → | 2001 | 685 |
| 6 | Vemurafenib: the first drug approved for BRAF-mutant cancer Hit paper breakdown → | 2012 | 670 |
| 7 | Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor Hit paper breakdown → | 2015 | 468 |
| 8 | Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases Hit paper breakdown → | 1998 | 445 |
| 9 | 2015 | 317 | |
| 10 | 2013 | 84 | |
| 11 | 1980 | 80 | |
| 12 | 2010 | 76 | |
| 13 | 1988 | 75 | |
| 14 | 1996 | 51 | |
| 15 | 1985 | 49 | |
| 16 | 2011 | 43 | |
| 17 | 1998 | 42 | |
| 18 | 1999 | 34 | |
| 19 | 2002 | 30 | |
| 20 | 1977 | 14 |
About Peter Hirth
Peter Hirth is a scholar working on Hematology, Molecular Biology, Organic Chemistry, Pulmonary and Respiratory Medicine and Endocrinology, having authored 24 papers that have together received 7.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Erythropoietin and Anemia Treatment (4 papers), Pulmonary Hypertension Research and Treatments (2 papers), Synthesis and biological activity (2 papers), RNA and protein synthesis mechanisms (1 paper), Bacteriophages and microbial interactions (1 paper), Immune cells in cancer (1 paper) and Musculoskeletal synovial abnormalities and treatments (1 paper). The work is most often cited by research in Molecular Biology (3.4k citations), Pulmonary and Respiratory Medicine (1.6k citations), Computational Theory and Mathematics (692 citations), Oncology (599 citations) and Organic Chemistry (692 citations). Peter Hirth has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Norbert Felix Voelkel, Rubin M. Tuder, Laimute Taraseviciene‐Stewart, Gerald McMahon, Yasunori Kasahara, Johannes L. Waltenberger, Cho Tang, Li Sun, Joseph Schlessinger and Brian K. Yeh. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, Canadian Journal of Physiology and Pharmacology and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.